PTH(1–84) Is Associated With Improved Quality of Life in Hypoparathyroidism Through 5 Years of Therapy | Zendy

Natalie E. Cusano | Zendy; Mishaela R. Rubin | Zendy; Donald J. McMahon | Zendy; Dinaz Irani | Zendy; Laura Anderson | Zendy; Elizabeth Levy | Zendy; John P. Bilezikian | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PTH(1–84) Is Associated With Improved Quality of Life in Hypoparathyroidism Through 5 Years of Therapy

Author(s) -

Natalie E. Cusano,

Mishaela R. Rubin,

Donald J. McMahon,

Dinaz Irani,

Laura Anderson,

Elizabeth Levy,

John P. Bilezikian

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-2267

Subject(s) - medicine , hypoparathyroidism , quality of life (healthcare) , mental health , vitality , sf 36 , physical therapy , normative , health related quality of life , psychiatry , disease , philosophy , nursing , theology , epistemology

In hypoparathyroidism, quality of life (QOL) is compromised as compared to normal subjects. We previously reported our results showing an association with recombinant human PTH(1-84) therapy in hypoparathyroidism and improvement in QOL measures for 1 year.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research